New Haven’s Biohaven Pharmaceuticals has quietly opened a second office outside Philadelphia to expand its commercial operation following its launch of a new migraine drug last year.

Biohaven confirmed to New Haven Biz that it opened the 21,000-square-foot Yardley, Pa. location to “serve as a centralized area for employees that live in the Pennsylvania to [New Jersey] corridor.”

New Haven architecture firm Svigals + Partners recently announced its role in designing the two-story location on its website, saying the recently refurbished space includes offices and a sales training center. 

Biohaven began leasing the location in March 2020, according to a recent regulatory filing, but it became fully operational during the third quarter of last year, the company said Monday. 

Read the full New Haven Biz article here.
View project gallery of images here.